메뉴 건너뛰기




Volumn 30, Issue , 2016, Pages 4-16

Neuroimaging biomarkers in Alzheimer's disease and other dementias

Author keywords

Alzheimer's disease; A ; Brain imaging; Neurodegenerative disorders; Positron emission tomography

Indexed keywords

AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; FLUORODEOXYGLUCOSE F 18;

EID: 84991974725     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2016.01.004     Document Type: Review
Times cited : (37)

References (231)
  • 4
    • 0034047021 scopus 로고    scopus 로고
    • Beta-amyloid deposition in the temporal lobe of patients with dementia with Lewy bodies: comparison with non-demented cases and Alzheimer's disease
    • Armstrong, R.A., Cairns, N.J., Lantos, P.L., Beta-amyloid deposition in the temporal lobe of patients with dementia with Lewy bodies: comparison with non-demented cases and Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 11 (2000), 187–192.
    • (2000) Dement. Geriatr. Cogn. Disord. , vol.11 , pp. 187-192
    • Armstrong, R.A.1    Cairns, N.J.2    Lantos, P.L.3
  • 6
    • 33745920161 scopus 로고    scopus 로고
    • Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo
    • Bateman, R.J., Munsell, L.Y., Morris, J.C., Swarm, R., Yarasheski, K.E., Holtzman, D.M., Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo. Nat. Med. 12 (2006), 856–861.
    • (2006) Nat. Med. , vol.12 , pp. 856-861
    • Bateman, R.J.1    Munsell, L.Y.2    Morris, J.C.3    Swarm, R.4    Yarasheski, K.E.5    Holtzman, D.M.6
  • 8
    • 84859052757 scopus 로고    scopus 로고
    • Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010
    • Beach, T.G., Monsell, S.E., Phillips, L.E., Kukull, W., Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010. J. Neuropathol. Exp. Neurol. 71 (2012), 266–273.
    • (2012) J. Neuropathol. Exp. Neurol. , vol.71 , pp. 266-273
    • Beach, T.G.1    Monsell, S.E.2    Phillips, L.E.3    Kukull, W.4
  • 11
    • 0025863618 scopus 로고
    • Neuropathological stageing of Alzheimer-related changes
    • Braak, H., Braak, E., Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. (Berl.) 82 (1991), 239–259.
    • (1991) Acta Neuropathol. (Berl.) , vol.82 , pp. 239-259
    • Braak, H.1    Braak, E.2
  • 12
    • 0030805991 scopus 로고    scopus 로고
    • Frequency of stages of Alzheimer-related lesions in different age categories
    • Braak, H., Braak, E., Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging 18 (1997), 351–357.
    • (1997) Neurobiol. Aging , vol.18 , pp. 351-357
    • Braak, H.1    Braak, E.2
  • 13
    • 79451471618 scopus 로고    scopus 로고
    • The pathological process underlying Alzheimer's disease in individuals under thirty
    • Braak, H., Del Tredici, K., The pathological process underlying Alzheimer's disease in individuals under thirty. Acta Neuropathol. 121 (2011), 171–181.
    • (2011) Acta Neuropathol. , vol.121 , pp. 171-181
    • Braak, H.1    Del Tredici, K.2
  • 14
    • 41949121294 scopus 로고    scopus 로고
    • The brain's default network: anatomy, function, and relevance to disease
    • Buckner, R.L., Andrews-Hanna, J.R., Schacter, D.L., The brain's default network: anatomy, function, and relevance to disease. Ann. N. Y. Acad. Sci. 1124 (2008), 1–38.
    • (2008) Ann. N. Y. Acad. Sci. , vol.1124 , pp. 1-38
    • Buckner, R.L.1    Andrews-Hanna, J.R.2    Schacter, D.L.3
  • 19
    • 84855369203 scopus 로고    scopus 로고
    • Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG
    • Carter, S.F., Scholl, M., Almkvist, O., Wall, A., Engler, H., Langstrom, B., Nordberg, A., Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG. J. Nucl. Med. 53 (2012), 37–46.
    • (2012) J. Nucl. Med. , vol.53 , pp. 37-46
    • Carter, S.F.1    Scholl, M.2    Almkvist, O.3    Wall, A.4    Engler, H.5    Langstrom, B.6    Nordberg, A.7
  • 20
    • 84874948210 scopus 로고    scopus 로고
    • Alzheimer disease: Abeta-independent processes-rethinking preclinical AD
    • Chetelat, G., Alzheimer disease: Abeta-independent processes-rethinking preclinical AD. Nat. Rev. Neurol. 9 (2013), 123–124.
    • (2013) Nat. Rev. Neurol. , vol.9 , pp. 123-124
    • Chetelat, G.1
  • 22
    • 20144379890 scopus 로고    scopus 로고
    • FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment
    • Chetelat, G., Eustache, F., Viader, F., De La Sayette, V., Pelerin, A., Mezenge, F., Hannequin, D., Dupuy, B., Baron, J.C., Desgranges, B., FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment. Neurocase 11 (2005), 14–25.
    • (2005) Neurocase , vol.11 , pp. 14-25
    • Chetelat, G.1    Eustache, F.2    Viader, F.3    De La Sayette, V.4    Pelerin, A.5    Mezenge, F.6    Hannequin, D.7    Dupuy, B.8    Baron, J.C.9    Desgranges, B.10
  • 28
    • 31544481908 scopus 로고    scopus 로고
    • Positron emission tomography diagnosis of Alzheimer's disease
    • x
    • Coleman, R.E., Positron emission tomography diagnosis of Alzheimer's disease. Neuroimaging Clin. N. Am. 15 (2005), 837–846 x.
    • (2005) Neuroimaging Clin. N. Am. , vol.15 , pp. 837-846
    • Coleman, R.E.1
  • 29
    • 77953300651 scopus 로고    scopus 로고
    • Brain microbleeds
    • Cordonnier, C., Brain microbleeds. Pract. Neurol. 10 (2010), 94–100.
    • (2010) Pract. Neurol. , vol.10 , pp. 94-100
    • Cordonnier, C.1
  • 31
    • 84903947419 scopus 로고    scopus 로고
    • Alzheimer's disease drug-development pipeline: few candidates, frequent failures
    • Cummings, J.L., Morstorf, T., Zhong, K., Alzheimer's disease drug-development pipeline: few candidates, frequent failures. Alzheimers Res. Ther., 6, 2014, 37.
    • (2014) Alzheimers Res. Ther. , vol.6 , pp. 37
    • Cummings, J.L.1    Morstorf, T.2    Zhong, K.3
  • 32
    • 0031902295 scopus 로고    scopus 로고
    • Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities
    • discussion S65–S17
    • Cummings, J.L., Vinters, H.V., Cole, G.M., Khachaturian, Z.S., Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology 51 (1998), S2–S17 discussion S65–S17.
    • (1998) Neurology , vol.51 , pp. S2-S17
    • Cummings, J.L.1    Vinters, H.V.2    Cole, G.M.3    Khachaturian, Z.S.4
  • 33
    • 0023737806 scopus 로고
    • A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques
    • Davies, L., Wolska, B., Hilbich, C., Multhaup, G., Martins, R., Simms, G., Beyreuther, K., Masters, C.L., A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques. Neurology 38 (1988), 1688–1693.
    • (1988) Neurology , vol.38 , pp. 1688-1693
    • Davies, L.1    Wolska, B.2    Hilbich, C.3    Multhaup, G.4    Martins, R.5    Simms, G.6    Beyreuther, K.7    Masters, C.L.8
  • 51
    • 79451470073 scopus 로고    scopus 로고
    • Tau pathology in children and young adults: can you still be unconditionally baptist?
    • Duyckaerts, C., Tau pathology in children and young adults: can you still be unconditionally baptist?. Acta Neuropathol. 121 (2011), 145–147.
    • (2011) Acta Neuropathol. , vol.121 , pp. 145-147
    • Duyckaerts, C.1
  • 57
    • 77949425172 scopus 로고    scopus 로고
    • Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's disease
    • Fagan, A.M., Mintun, M.A., Shah, A.R., Aldea, P., Roe, C.M., Mach, R.H., Marcus, D., Morris, J.C., Holtzman, D.M., Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's disease. EMBO Mol. Med. 1 (2009), 371–380.
    • (2009) EMBO Mol. Med. , vol.1 , pp. 371-380
    • Fagan, A.M.1    Mintun, M.A.2    Shah, A.R.3    Aldea, P.4    Roe, C.M.5    Mach, R.H.6    Marcus, D.7    Morris, J.C.8    Holtzman, D.M.9
  • 58
    • 33947223454 scopus 로고    scopus 로고
    • Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults
    • Fagan, A.M., Roe, C.M., Xiong, C., Mintun, M.A., Morris, J.C., Holtzman, D.M., Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults. Arch. Neurol. 64 (2007), 343–349.
    • (2007) Arch. Neurol. , vol.64 , pp. 343-349
    • Fagan, A.M.1    Roe, C.M.2    Xiong, C.3    Mintun, M.A.4    Morris, J.C.5    Holtzman, D.M.6
  • 59
    • 54049139597 scopus 로고    scopus 로고
    • Superficial siderosis: a potential diagnostic marker of cerebral amyloid angiopathy in Alzheimer disease
    • Feldman, H.H., Maia, L.F., Mackenzie, I.R., Forster, B.B., Martzke, J., Woolfenden, A., Superficial siderosis: a potential diagnostic marker of cerebral amyloid angiopathy in Alzheimer disease. Stroke 39 (2008), 2894–2897.
    • (2008) Stroke , vol.39 , pp. 2894-2897
    • Feldman, H.H.1    Maia, L.F.2    Mackenzie, I.R.3    Forster, B.B.4    Martzke, J.5    Woolfenden, A.6
  • 62
    • 77949701876 scopus 로고    scopus 로고
    • High PIB retention in Alzheimer's disease is an early event with complex relationship with CSF biomarkers and functional parameters
    • Forsberg, A., Almkvist, O., Engler, H., Wall, A., Langstrom, B., Nordberg, A., High PIB retention in Alzheimer's disease is an early event with complex relationship with CSF biomarkers and functional parameters. Curr. Alzheimer Res. 7 (2010), 56–66.
    • (2010) Curr. Alzheimer Res. , vol.7 , pp. 56-66
    • Forsberg, A.1    Almkvist, O.2    Engler, H.3    Wall, A.4    Langstrom, B.5    Nordberg, A.6
  • 64
    • 84869106754 scopus 로고    scopus 로고
    • When, where, and how does Alzheimer's disease start?
    • Fox, N., When, where, and how does Alzheimer's disease start?. Lancet Neurol. 11 (2012), 1017–1018.
    • (2012) Lancet Neurol. , vol.11 , pp. 1017-1018
    • Fox, N.1
  • 72
    • 0026546599 scopus 로고
    • An ‘anatomical cascade hypothesis’ for Alzheimer's disease
    • Hardy, J., An ‘anatomical cascade hypothesis’ for Alzheimer's disease. Trends Neurosci. 15 (1992), 200–201.
    • (1992) Trends Neurosci. , vol.15 , pp. 200-201
    • Hardy, J.1
  • 73
    • 0031052381 scopus 로고    scopus 로고
    • Amyloid, the presenilins and Alzheimer's disease
    • Hardy, J., Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20 (1997), 154–159.
    • (1997) Trends Neurosci. , vol.20 , pp. 154-159
    • Hardy, J.1
  • 74
    • 0037135111 scopus 로고    scopus 로고
    • The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics
    • Hardy, J., Selkoe, D.J., The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002), 353–356.
    • (2002) Science , vol.297 , pp. 353-356
    • Hardy, J.1    Selkoe, D.J.2
  • 76
    • 35248886083 scopus 로고    scopus 로고
    • Semantic dementia: a unique clinicopathological syndrome
    • Hodges, J.R., Patterson, K., Semantic dementia: a unique clinicopathological syndrome. Lancet Neurol. 6 (2007), 1004–1014.
    • (2007) Lancet Neurol. , vol.6 , pp. 1004-1014
    • Hodges, J.R.1    Patterson, K.2
  • 77
    • 0036468772 scopus 로고    scopus 로고
    • Alzheimer's disease and Down's syndrome: roles of APP, trophic factors and ACh
    • Isacson, O., Seo, H., Lin, L., Albeck, D., Granholm, A.C., Alzheimer's disease and Down's syndrome: roles of APP, trophic factors and ACh. Trends Neurosci. 25 (2002), 79–84.
    • (2002) Trends Neurosci. , vol.25 , pp. 79-84
    • Isacson, O.1    Seo, H.2    Lin, L.3    Albeck, D.4    Granholm, A.C.5
  • 78
    • 84922073605 scopus 로고    scopus 로고
    • PART and SNAP
    • Jack, C.R. Jr., PART and SNAP. Acta Neuropathol. 128 (2014), 773–776.
    • (2014) Acta Neuropathol. , vol.128 , pp. 773-776
    • Jack, C.R.1
  • 79
    • 84890528022 scopus 로고    scopus 로고
    • Biomarker modeling of Alzheimer's disease
    • Jack, C.R. Jr., Holtzman, D.M., Biomarker modeling of Alzheimer's disease. Neuron 80 (2013), 1347–1358.
    • (2013) Neuron , vol.80 , pp. 1347-1358
    • Jack, C.R.1    Holtzman, D.M.2
  • 88
    • 34548219060 scopus 로고    scopus 로고
    • What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?
    • Jagust, W., Reed, B., Mungas, D., Ellis, W., Decarli, C., What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?. Neurology 69 (2007), 871–877.
    • (2007) Neurology , vol.69 , pp. 871-877
    • Jagust, W.1    Reed, B.2    Mungas, D.3    Ellis, W.4    Decarli, C.5
  • 89
    • 84871001204 scopus 로고    scopus 로고
    • Apolipoprotein E, not fibrillar beta-amyloid, reduces cerebral glucose metabolism in normal aging
    • Jagust, W.J., Landau, S.M., Alzheimer's Disease Neuroimaging Initiative, Apolipoprotein E, not fibrillar beta-amyloid, reduces cerebral glucose metabolism in normal aging. J. Neurosci. 32 (2012), 18227–18233.
    • (2012) J. Neurosci. , vol.32 , pp. 18227-18233
    • Jagust, W.J.1    Landau, S.M.2    Alzheimer's Disease Neuroimaging Initiative3
  • 91
    • 0002123978 scopus 로고
    • Morphology of Alzheimer disease and related disorders
    • K. Maurer P. Riederer H. Beckmann Springer-Verlag Berlin
    • Jellinger, K., Morphology of Alzheimer disease and related disorders. Maurer, K., Riederer, P., Beckmann, H., (eds.) Alzheimer Disease: Epidemiology, Neuropathology, Neurochemistry, and Clinics, 1990, Springer-Verlag, Berlin, 61–77.
    • (1990) Alzheimer Disease: Epidemiology, Neuropathology, Neurochemistry, and Clinics , pp. 61-77
    • Jellinger, K.1
  • 92
    • 77953366086 scopus 로고    scopus 로고
    • Con: can neuropathology really confirm the exact diagnosis?
    • Jellinger, K.A., Con: can neuropathology really confirm the exact diagnosis?. Alzheimers Res. Ther., 2, 2010, 11.
    • (2010) Alzheimers Res. Ther. , vol.2 , pp. 11
    • Jellinger, K.A.1
  • 93
    • 14844327519 scopus 로고    scopus 로고
    • Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease
    • Jellinger, K.A., Attems, J., Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease. J. Neurol. Sci. 229–230 (2005), 37–41.
    • (2005) J. Neurol. Sci. , vol.229-230 , pp. 37-41
    • Jellinger, K.A.1    Attems, J.2
  • 94
    • 0031593592 scopus 로고    scopus 로고
    • Neuropathology of Alzheimer's disease: a critical update
    • Jellinger, K.A., Bancher, C., Neuropathology of Alzheimer's disease: a critical update. J. Neural Transm. Suppl. 54 (1998), 77–95.
    • (1998) J. Neural Transm. Suppl. , vol.54 , pp. 77-95
    • Jellinger, K.A.1    Bancher, C.2
  • 97
    • 0033859794 scopus 로고    scopus 로고
    • The epidemic of Alzheimer's disease. How can we manage the costs?
    • Johnson, N., Davis, T., Bosanquet, N., The epidemic of Alzheimer's disease. How can we manage the costs?. Pharmacoeconomics 18 (2000), 215–223.
    • (2000) Pharmacoeconomics , vol.18 , pp. 215-223
    • Johnson, N.1    Davis, T.2    Bosanquet, N.3
  • 102
    • 0022414054 scopus 로고
    • Diagnosis of Alzheimer's disease
    • Khachaturian, Z.S., Diagnosis of Alzheimer's disease. Arch. Neurol. 42 (1985), 1097–1105.
    • (1985) Arch. Neurol. , vol.42 , pp. 1097-1105
    • Khachaturian, Z.S.1
  • 103
    • 80955137862 scopus 로고    scopus 로고
    • Amyloid imaging as a biomarker for cerebral beta-amyloidosis and risk prediction for Alzheimer dementia
    • Klunk, W.E., Amyloid imaging as a biomarker for cerebral beta-amyloidosis and risk prediction for Alzheimer dementia. Neurobiol. Aging 32:Suppl. 1 (2011), S20–36.
    • (2011) Neurobiol. Aging , vol.32 , pp. S20-36
    • Klunk, W.E.1
  • 106
    • 84876273738 scopus 로고    scopus 로고
    • Alzheimer disease biomarkers and insights into mild cognitive impairment
    • Knopman, D.S., Alzheimer disease biomarkers and insights into mild cognitive impairment. Neurology 80 (2013), 978–980.
    • (2013) Neurology , vol.80 , pp. 978-980
    • Knopman, D.S.1
  • 108
    • 0035957075 scopus 로고    scopus 로고
    • Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria
    • Knudsen, K.A., Rosand, J., Karluk, D., Greenberg, S.M., Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology 56 (2001), 537–539.
    • (2001) Neurology , vol.56 , pp. 537-539
    • Knudsen, K.A.1    Rosand, J.2    Karluk, D.3    Greenberg, S.M.4
  • 111
    • 34248579112 scopus 로고    scopus 로고
    • 2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6-(2-[fluoro]ethoxy) benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients
    • Kudo, Y., Okamura, N., Furumoto, S., Tashiro, M., Furukawa, K., Maruyama, M., Itoh, M., Iwata, R., Yanai, K., Arai, H., 2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6-(2-[fluoro]ethoxy) benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients. J. Nucl. Med. 48 (2007), 553–561.
    • (2007) J. Nucl. Med. , vol.48 , pp. 553-561
    • Kudo, Y.1    Okamura, N.2    Furumoto, S.3    Tashiro, M.4    Furukawa, K.5    Maruyama, M.6    Itoh, M.7    Iwata, R.8    Yanai, K.9    Arai, H.10
  • 115
    • 80054061066 scopus 로고    scopus 로고
    • Subtypes of progressive aphasia: application of the international consensus criteria and validation using {beta}-amyloid imaging
    • Leyton, C.E., Villemagne, V.L., Savage, S., Pike, K.E., Ballard, K.J., Piguet, O., Burrell, J.R., Rowe, C.C., Hodges, J.R., Subtypes of progressive aphasia: application of the international consensus criteria and validation using {beta}-amyloid imaging. Brain 134:Pt 10 (2011), 3030–3043.
    • (2011) Brain , vol.134 , pp. 3030-3043
    • Leyton, C.E.1    Villemagne, V.L.2    Savage, S.3    Pike, K.E.4    Ballard, K.J.5    Piguet, O.6    Burrell, J.R.7    Rowe, C.C.8    Hodges, J.R.9
  • 116
    • 33748744268 scopus 로고    scopus 로고
    • Amyloid plaques in transmissible spongiform encephalopathies (prion diseases)
    • Liberski, P.P., Amyloid plaques in transmissible spongiform encephalopathies (prion diseases). Folia Neuropathol. 42:Suppl. B (2004), 109–119.
    • (2004) Folia Neuropathol. , vol.42 , pp. 109-119
    • Liberski, P.P.1
  • 118
    • 44949162153 scopus 로고    scopus 로고
    • Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions
    • Mackenzie, I.R., Foti, D., Woulfe, J., Hurwitz, T.A., Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions. Brain 131 (2008), 1282–1293.
    • (2008) Brain , vol.131 , pp. 1282-1293
    • Mackenzie, I.R.1    Foti, D.2    Woulfe, J.3    Hurwitz, T.A.4
  • 120
    • 0035834076 scopus 로고    scopus 로고
    • Beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease
    • Masliah, E., Rockenstein, E., Veinbergs, I., Sagara, Y., Mallory, M., Hashimoto, M., Mucke, L., Beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 12245–12250.
    • (2001) Proc. Natl. Acad. Sci. U. S. A. , vol.98 , pp. 12245-12250
    • Masliah, E.1    Rockenstein, E.2    Veinbergs, I.3    Sagara, Y.4    Mallory, M.5    Hashimoto, M.6    Mucke, L.7
  • 121
    • 33750904708 scopus 로고    scopus 로고
    • Neuropathology of Alzheimer's disease
    • A. Burns J. O'Brien D. Ames 3rd ed. Hodder Arnold London
    • Masters, C.L., Neuropathology of Alzheimer's disease. Burns, A., O'Brien, J., Ames, D., (eds.) Dementia, 3rd ed., 2005, Hodder Arnold, London, 393–407.
    • (2005) Dementia , pp. 393-407
    • Masters, C.L.1
  • 122
    • 33745039545 scopus 로고    scopus 로고
    • The neuropathology of Alzheimer's disease in the year 2005
    • M.F. Beal A.E. Lang A.C. Ludolph Cambridge University Press Cambridge
    • Masters, C.L., Beyreuther, K., The neuropathology of Alzheimer's disease in the year 2005. Beal, M.F., Lang, A.E., Ludolph, A.C., (eds.) Neurodegenerative Diseases: Neurobiology, Pathogenesis and Therapeutics, 2005, Cambridge University Press, Cambridge, 433–440.
    • (2005) Neurodegenerative Diseases: Neurobiology, Pathogenesis and Therapeutics , pp. 433-440
    • Masters, C.L.1    Beyreuther, K.2
  • 123
    • 33750603844 scopus 로고    scopus 로고
    • Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathway
    • Masters, C.L., Beyreuther, K., Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathway. Brain 129 (2006), 2823–2839.
    • (2006) Brain , vol.129 , pp. 2823-2839
    • Masters, C.L.1    Beyreuther, K.2
  • 124
    • 33745027879 scopus 로고    scopus 로고
    • Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics
    • Masters, C.L., Cappai, R., Barnham, K.J., Villemagne, V.L., Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics. J. Neurochem. 97 (2006), 1700–1725.
    • (2006) J. Neurochem. , vol.97 , pp. 1700-1725
    • Masters, C.L.1    Cappai, R.2    Barnham, K.J.3    Villemagne, V.L.4
  • 130
    • 1942518747 scopus 로고    scopus 로고
    • Dementia with Lewy bodies and Parkinson's disease
    • McKeith, I.G., Mosimann, U.P., Dementia with Lewy bodies and Parkinson's disease. Parkinsonism Relat. Disord. 10:Suppl. 1 (2004), S15–18.
    • (2004) Parkinsonism Relat. Disord. , vol.10 , pp. S15-18
    • McKeith, I.G.1    Mosimann, U.P.2
  • 132
    • 0036931159 scopus 로고    scopus 로고
    • Tau neurofibrillary pathology and microtubule stability
    • Michaelis, M.L., Dobrowsky, R.T., Li, G., Tau neurofibrillary pathology and microtubule stability. J. Mol. Neurosci. 19 (2002), 289–293.
    • (2002) J. Mol. Neurosci. , vol.19 , pp. 289-293
    • Michaelis, M.L.1    Dobrowsky, R.T.2    Li, G.3
  • 135
    • 84863722678 scopus 로고    scopus 로고
    • Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia
    • Morris, J.C., Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia. Arch. Neurol., 2012, 10.1001/archneurol.2011.3152.
    • (2012) Arch. Neurol.
    • Morris, J.C.1
  • 137
    • 0035168927 scopus 로고    scopus 로고
    • Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease
    • Morris, J.C., Price, A.L., Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J. Mol. Neurosci. 17 (2001), 101–118.
    • (2001) J. Mol. Neurosci. , vol.17 , pp. 101-118
    • Morris, J.C.1    Price, A.L.2
  • 138
  • 145
    • 0038731434 scopus 로고    scopus 로고
    • Dementia
    • 2nd ed. Arnold London
    • O'Brien, J., Ames, D., Burns, A., Dementia. 2nd ed., 2000, Arnold, London.
    • (2000)
    • O'Brien, J.1    Ames, D.2    Burns, A.3
  • 152
    • 0034087231 scopus 로고    scopus 로고
    • Mild cognitive impairment: transition between aging and Alzheimer's disease
    • Petersen, R.C., Mild cognitive impairment: transition between aging and Alzheimer's disease. Neurologia 15 (2000), 93–101.
    • (2000) Neurologia , vol.15 , pp. 93-101
    • Petersen, R.C.1
  • 157
    • 78149488153 scopus 로고    scopus 로고
    • Amyloid-independent mechanisms in Alzheimer's disease pathogenesis
    • Pimplikar, S.W., Nixon, R.A., Robakis, N.K., Shen, J., Tsai, L.H., Amyloid-independent mechanisms in Alzheimer's disease pathogenesis. J. Neurosci. 30 (2010), 14946–14954.
    • (2010) J. Neurosci. , vol.30 , pp. 14946-14954
    • Pimplikar, S.W.1    Nixon, R.A.2    Robakis, N.K.3    Shen, J.4    Tsai, L.H.5
  • 162
    • 77950665407 scopus 로고    scopus 로고
    • Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management
    • Rabinovici, G.D., Miller, B.L., Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management. CNS Drugs 24 (2010), 375–398.
    • (2010) CNS Drugs , vol.24 , pp. 375-398
    • Rabinovici, G.D.1    Miller, B.L.2
  • 167
    • 33947303240 scopus 로고    scopus 로고
    • Susceptibility of hippocampal neurons to Abeta peptide toxicity is associated with perturbation of Ca2+ homeostasis
    • Resende, R., Pereira, C., Agostinho, P., Vieira, A.P., Malva, J.O., Oliveira, C.R., Susceptibility of hippocampal neurons to Abeta peptide toxicity is associated with perturbation of Ca2+ homeostasis. Brain Res. 1143 (2007), 11–21.
    • (2007) Brain Res. , vol.1143 , pp. 11-21
    • Resende, R.1    Pereira, C.2    Agostinho, P.3    Vieira, A.P.4    Malva, J.O.5    Oliveira, C.R.6
  • 170
    • 0042266332 scopus 로고    scopus 로고
    • Electrophysiological studies on the hippocampus and prefrontal cortex assessing the effects of amyloidosis in amyloid precursor protein 23 transgenic mice
    • Roder, S., Danober, L., Pozza, M.F., Lingenhoehl, K., Wiederhold, K.H., Olpe, H.R., Electrophysiological studies on the hippocampus and prefrontal cortex assessing the effects of amyloidosis in amyloid precursor protein 23 transgenic mice. Neuroscience 120 (2003), 705–720.
    • (2003) Neuroscience , vol.120 , pp. 705-720
    • Roder, S.1    Danober, L.2    Pozza, M.F.3    Lingenhoehl, K.4    Wiederhold, K.H.5    Olpe, H.R.6
  • 171
    • 55949096820 scopus 로고    scopus 로고
    • Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh compound B uptake
    • Roe, C.M., Mintun, M.A., D'Angelo, G., Xiong, C., Grant, E.A., Morris, J.C., Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh compound B uptake. Arch. Neurol. 65 (2008), 1467–1471.
    • (2008) Arch. Neurol. , vol.65 , pp. 1467-1471
    • Roe, C.M.1    Mintun, M.A.2    D'Angelo, G.3    Xiong, C.4    Grant, E.A.5    Morris, J.C.6
  • 172
    • 0029913271 scopus 로고    scopus 로고
    • Clinical and neuroimaging features of familial Alzheimer's disease
    • Rossor, M.N., Kennedy, A.M., Frackowiak, R.S., Clinical and neuroimaging features of familial Alzheimer's disease. Ann. N. Y. Acad. Sci. 777 (1996), 49–56.
    • (1996) Ann. N. Y. Acad. Sci. , vol.777 , pp. 49-56
    • Rossor, M.N.1    Kennedy, A.M.2    Frackowiak, R.S.3
  • 178
    • 84883742951 scopus 로고    scopus 로고
    • Dementia: Mild cognitive impairment—amyloid and beyond
    • Scheltens, P., Dementia: Mild cognitive impairment—amyloid and beyond. Nat. Rev. Neurol. 9 (2013), 493–495.
    • (2013) Nat. Rev. Neurol. , vol.9 , pp. 493-495
    • Scheltens, P.1
  • 179
    • 79960825638 scopus 로고    scopus 로고
    • How golden is the gold standard of neuropathology in dementia?
    • Scheltens, P., Rockwood, K., How golden is the gold standard of neuropathology in dementia?. Alzheimers Dement. 7 (2011), 486–489.
    • (2011) Alzheimers Dement. , vol.7 , pp. 486-489
    • Scheltens, P.1    Rockwood, K.2
  • 180
    • 77957264418 scopus 로고    scopus 로고
    • The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia
    • Schulz-Schaeffer, W.J., The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia. Acta Neuropathol. 120 (2010), 131–143.
    • (2010) Acta Neuropathol. , vol.120 , pp. 131-143
    • Schulz-Schaeffer, W.J.1
  • 183
    • 0036660882 scopus 로고    scopus 로고
    • Added clinical benefit of incorporating 2-deoxy-2-[18F]fluoro-D-glucose with positron emission tomography into the clinical evaluation of patients with cognitive impairment
    • Silverman, D.H., Cummings, J.L., Small, G.W., Gambhir, S.S., Chen, W., Czernin, J., Phelps, M.E., Added clinical benefit of incorporating 2-deoxy-2-[18F]fluoro-D-glucose with positron emission tomography into the clinical evaluation of patients with cognitive impairment. Mol. Imaging Biol. 4 (2002), 283–293.
    • (2002) Mol. Imaging Biol. , vol.4 , pp. 283-293
    • Silverman, D.H.1    Cummings, J.L.2    Small, G.W.3    Gambhir, S.S.4    Chen, W.5    Czernin, J.6    Phelps, M.E.7
  • 186
    • 56349119351 scopus 로고    scopus 로고
    • Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis
    • Small, S.A., Duff, K., Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis. Neuron 60 (2008), 534–542.
    • (2008) Neuron , vol.60 , pp. 534-542
    • Small, S.A.1    Duff, K.2
  • 187
    • 34447099564 scopus 로고    scopus 로고
    • Frontotemporal lobar degeneration: clinical and pathological relationships
    • Snowden, J., Neary, D., Mann, D., Frontotemporal lobar degeneration: clinical and pathological relationships. Acta Neuropathol. 114 (2007), 31–38.
    • (2007) Acta Neuropathol. , vol.114 , pp. 31-38
    • Snowden, J.1    Neary, D.2    Mann, D.3
  • 190
    • 77954173001 scopus 로고    scopus 로고
    • Pro: can biomarkers be gold standards in Alzheimer's disease?
    • Sperling, R., Johnson, K., Pro: can biomarkers be gold standards in Alzheimer's disease?. Alzheimers Res. Ther., 2, 2010, 17.
    • (2010) Alzheimers Res. Ther. , vol.2 , pp. 17
    • Sperling, R.1    Johnson, K.2
  • 192
    • 82655173747 scopus 로고    scopus 로고
    • Testing the right target and right drug at the right stage
    • Sperling, R.A., Jack, C.R. Jr., Aisen, P.S., Testing the right target and right drug at the right stage. Sci. Transl. Med. 3 (2011), 111–133.
    • (2011) Sci. Transl. Med. , vol.3 , pp. 111-133
    • Sperling, R.A.1    Jack, C.R.2    Aisen, P.S.3
  • 197
    • 73549106106 scopus 로고    scopus 로고
    • Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition
    • Storandt, M., Mintun, M.A., Head, D., Morris, J.C., Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition. Arch. Neurol. 66 (2009), 1476–1481.
    • (2009) Arch. Neurol. , vol.66 , pp. 1476-1481
    • Storandt, M.1    Mintun, M.A.2    Head, D.3    Morris, J.C.4
  • 198
    • 0037465449 scopus 로고    scopus 로고
    • CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study
    • Strozyk, D., Blennow, K., White, L.R., Launer, L.J., CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study. Neurology 60 (2003), 652–656.
    • (2003) Neurology , vol.60 , pp. 652-656
    • Strozyk, D.1    Blennow, K.2    White, L.R.3    Launer, L.J.4
  • 199
    • 23644453302 scopus 로고    scopus 로고
    • The use of biomarkers in the elderly: current and future challenges
    • Sunderland, T., Gur, R.E., Arnold, S.E., The use of biomarkers in the elderly: current and future challenges. Biol. Psychiatry 58 (2005), 272–276.
    • (2005) Biol. Psychiatry , vol.58 , pp. 272-276
    • Sunderland, T.1    Gur, R.E.2    Arnold, S.E.3
  • 205
    • 84888201046 scopus 로고    scopus 로고
    • Longitudinal change in CSF Tau and Abeta biomarkers for up to 48 months in ADNI
    • Toledo, J.B., Xie, S.X., Trojanowski, J.Q., Shaw, L.M., Longitudinal change in CSF Tau and Abeta biomarkers for up to 48 months in ADNI. Acta Neuropathol. 126 (2013), 659–670.
    • (2013) Acta Neuropathol. , vol.126 , pp. 659-670
    • Toledo, J.B.1    Xie, S.X.2    Trojanowski, J.Q.3    Shaw, L.M.4
  • 206
    • 33846205518 scopus 로고    scopus 로고
    • The peripheral benzodiazepine receptor (Translocator protein 18 kDa) in microglia: from pathology to imaging
    • Venneti, S., Lopresti, B.J., Wiley, C.A., The peripheral benzodiazepine receptor (Translocator protein 18 kDa) in microglia: from pathology to imaging. Prog. Neurobiol. 80 (2006), 308–322.
    • (2006) Prog. Neurobiol. , vol.80 , pp. 308-322
    • Venneti, S.1    Lopresti, B.J.2    Wiley, C.A.3
  • 219
    • 77956642230 scopus 로고    scopus 로고
    • Amyloid ligands for dementia
    • Villemagne, V.L., Rowe, C.C., Amyloid ligands for dementia. PET Clin. 5 (2010), 33–53.
    • (2010) PET Clin. , vol.5 , pp. 33-53
    • Villemagne, V.L.1    Rowe, C.C.2
  • 221
    • 84878912597 scopus 로고    scopus 로고
    • Can tauopathy shake the amyloid cascade hypothesis?
    • Vishnu, V.Y., Can tauopathy shake the amyloid cascade hypothesis?. Nat. Rev. Neurol., 9, 2013, 356.
    • (2013) Nat. Rev. Neurol. , vol.9 , pp. 356
    • Vishnu, V.Y.1
  • 223
    • 0037457354 scopus 로고    scopus 로고
    • Cerebrospinal fluid biomarkers for disease stage and intensity in cognitively impaired patients
    • Wahlund, L.O., Blennow, K., Cerebrospinal fluid biomarkers for disease stage and intensity in cognitively impaired patients. Neurosci. Lett. 339 (2003), 99–102.
    • (2003) Neurosci. Lett. , vol.339 , pp. 99-102
    • Wahlund, L.O.1    Blennow, K.2
  • 224
    • 84873742707 scopus 로고    scopus 로고
    • Dementia in 2012: further insights into Alzheimer disease pathogenesis
    • Weiner, M.W., Dementia in 2012: further insights into Alzheimer disease pathogenesis. Nat. Rev. Neurol. 9 (2013), 65–66.
    • (2013) Nat. Rev. Neurol. , vol.9 , pp. 65-66
    • Weiner, M.W.1
  • 225
    • 78049254530 scopus 로고    scopus 로고
    • Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease
    • Weller, R.O., Preston, S.D., Subash, M., Carare, R.O., Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease. Alzheimers Res. Ther., 1, 2009, 6.
    • (2009) Alzheimers Res. Ther. , vol.1 , pp. 6
    • Weller, R.O.1    Preston, S.D.2    Subash, M.3    Carare, R.O.4
  • 226
    • 41149157850 scopus 로고    scopus 로고
    • A new integrative model of cerebral activation, deactivation and default mode function in Alzheimer's disease
    • Wermke, M., Sorg, C., Wohlschlager, A.M., Drzezga, A., A new integrative model of cerebral activation, deactivation and default mode function in Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imaging 35:Suppl. 1 (2008), S12–24.
    • (2008) Eur. J. Nucl. Med. Mol. Imaging , vol.35 , pp. S12-24
    • Wermke, M.1    Sorg, C.2    Wohlschlager, A.M.3    Drzezga, A.4
  • 227
    • 58449115240 scopus 로고    scopus 로고
    • Carbon 11-labeled Pittsburgh compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease
    • Wiley, C.A., Lopresti, B.J., Venneti, S., Price, J., Klunk, W.E., DeKosky, S.T., Mathis, C.A., Carbon 11-labeled Pittsburgh compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease. Arch. Neurol. 66 (2009), 60–67.
    • (2009) Arch. Neurol. , vol.66 , pp. 60-67
    • Wiley, C.A.1    Lopresti, B.J.2    Venneti, S.3    Price, J.4    Klunk, W.E.5    DeKosky, S.T.6    Mathis, C.A.7
  • 228
    • 84890423856 scopus 로고    scopus 로고
    • Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people
    • Wirth, M., Villeneuve, S., Haase, C.M., Madison, C.M., Oh, H., Landau, S.M., Rabinovici, G.D., Jagust, W.J., Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people. JAMA Neurol. 70 (2013), 1512–1519.
    • (2013) JAMA Neurol. , vol.70 , pp. 1512-1519
    • Wirth, M.1    Villeneuve, S.2    Haase, C.M.3    Madison, C.M.4    Oh, H.5    Landau, S.M.6    Rabinovici, G.D.7    Jagust, W.J.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.